Daniel Gorelick

Happy 15th anniversary, Retraction Watch Once upon a time, a long time ago, two science journalists had an idea for a blog about retractions. And on Aug. 3, 2010, Retraction Watch launched, detailing in the first post why retractions matt…

Once upon a time, two science journalists had an idea for a blog about retractions. And on Aug. 3, 2010, Retraction Watch launched.

And now, 15 years and 6,700 posts later, that work seems more important than ever.

Happy 15th anniversary, Retraction Watch.

As scientists, we all need to speak up. Thanks, Guillermo Oliver and @labonnelab.bsky.social for all the science advocacy. 🔬

But we ALL need to be telling our friends, family, and neighbors how important science is. Educate them about the medical cures that came from basic discoveries.

#science

It doesn't have to be this way. In Economics, the gatekeeper journals (equivalent to our C/N/S) are all published by university presses or nonprofit societies, inexpensive to read or publish in. If NIH puts an absurdly low cap on APCs, perhaps we can adopt the Econ model

NIH published a journal, regarded as the top journal in its field (toxicology), called Environmental Health Perspectives, free to read & free to publish in, but it stopped accepting submissions soon after Trump took office ehp.niehs.nih.gov/do/10.5555/b...

I have many thoughts on this, which I will share with NIH

Using information from 7,350 journals, the average APC reported worldwide was $1,235.51 ($0.01 to $8,900.00). One APC was removed from analysis as an extreme outlier ($15,584,416.00 USD). What journal was this???

I have thoughts & I'm sure you do too. Submit by Sep 15 grants.nih.gov/grants/guide...

YouTube video by PBS NewsHour What Columbia's settlement with the Trump administration means for higher education

Michael Roth, the college president we need www.youtube.com/watch?v=9O2S...

Transitions in development – an interview with Jeffrey Farrell

@jeffreyafarrell.bsky.social talks about becoming a group leader, his insights on advocacy for developmental biology and his belief in unifying single-cell biology with classical approaches.

journals.biologists.com/dev/article/...

This is a useful summary of how some major publishers are responding to the new NIH policy. We've just updated our policies at @biologists.bsky.social: @dev-journal.bsky.social @jcellsci.bsky.social and @jexpbiol.bsky.social will allow authors to deposit the accepted version with zero embargo.

The Company of Biologists 100 logo to the left and QR code to the right. Portrait of Andrea Brand to the left, text to the right 100 extraordinary biologists Andrea Brand Andrea Brand authored Development’s most cited paper, originating the GAL4 system for targeted gene expression. Andrea is the Chair of Department of Cell Biology and Director of the Regenerative Medicine Institute at NYU School of Medicine, USA, investigating neural stem cells in human brain organoids and Drosophila. #100biologists #biologists100

We are also highlighting Andrea Brand, who authored @dev-journal.bsky.social‘s most cited paper, as an extraordinary biologist this week. #100biologists

@biologyopen.bsky.social is drilling down into the nitty gritty details of how paying peer reviewers would work, and hopefully being transparent about it journals.biologists.com/bio/pages/fa...

Inspiring. Thank you!

YouTube video by The Company of Biologists spotLights Ep 11: preLights in conversation with Daniel Gorelick and Alejandra Clark

I spoke with Alejandra Clark and @danielgorelick.bsky.social about the fast and fair peer review initiative from @biologyopen.bsky.social. They’re cutting down review times and compensating peer reviewers for their work! #PeerReview #FastAndFair (2/5) www.youtube.com/watch?v=mM6m...

Support the NASA Voyager Declaration Now! — STAND UP FOR SCIENCE Your solidarity with the NASA heroes helps their fight to preserve NASA's vital missions.

The Voyager Declaration from courageous NASA staff members was just sent. Please take a look and sign on in support.

@standupforscience.bsky.social

www.standupforscience.net/nasa-voyager...

Let’s hope this meeting today is productive.

Will anyone review this paper? Screening, sorting, and the feedback cycles that imperil peer review Scholarly publishing relies on peer review to identify the best science. Yet finding willing and qualified reviewers to evaluate manuscripts has become an increasingly challenging task, possibly even ...

1. Kevin Gross and I just posted a new science-of-science preprint.

This one explores the looming peer review crisis. As many of you know, it's becoming significantly more difficult for journal editors to find scholars willing to serve as peer reviewers for submitted manuscripts.

“there is evidence that the use of AI tools has enabled Principal Investigators to submit more than 40 distinct applications in a single application submission round” would love to see this evidence grants.nih.gov/grants/guide...

Key question is how this got past peer review & what is the journal doing to prevent this in the future

FocalPlane features... membrane trafficking - apply to give a talk - FocalPlane FocalPlane features... membrane trafficking - apply to give a talk - News

📢Call for speakers

We are looking for ECRs to speak in our mini-symposium run together with the popular membrane trafficking webinar series organised by ‪@franbottanelli.bsky.social @felixmendu.bsky.social & @ishier.bsky.social.

focalplane.biologists.com/2025/07/14/f...

Apply by 24 August

This is exactly right. So far we haven’t gotten as many dev biol or fly or worm or fish manuscripts as other areas of biology. Would love to get more and use our panel of reviewers with this expertise. Encourage your colleagues to submit to @biologyopen.bsky.social

@mads100tist.bsky.social the reason you haven’t been asked to review is because we haven’t gotten any manuscripts in your areas of expertise. Encourage your colleagues to submit to @biologyopen.bsky.social

We’ve had hundreds of people sign up. As a small journal we’ve only sent 60 manuscripts out for peer review this year. As a journal with broad scope only a small fraction of those are neuroscience

IMPORTANT IMPORTANT IMPORTANT IMPORTANT

Please watch the workshop video and COMMENT by 5:00 Monday 7/14

This is the source of the "no more model organism only grants in NIH-funded research" decree.

Fast & Fair peer review A new initiative offering high-quality peer review within 7 working days of submission Biology Open logo

Looking to get involved in peer review?

Check out the Fast & Fair initiative run by @biologyopen.bsky.social.

journals.biologists.com/bio/pages/fa...

#PeerReview #PaidWork #Journals #Academia #Research #Biology #BiologyOpen

Graph showing historical NOAs for new SBIR awards by month with sharp increases beginning in June and ending in September, when new NOAs go to 0. Corresponding with the end of the fiscal year. The NOAs for 2025 are shown separately and have been below 1 and 2 standard deviations from the mean all year, with no sharp increase yet.

Graph showing historical NOAs for new year-1 R01 grants by month with sharp increases beginning in June and ending in September, when new NOAs go to 0. Corresponding with the end of the fiscal year. The NOAs for 2025 are shown separately and have been below 1 and 2 standard deviations from the mean all year, with no sharp increase yet.

We are now in the time of year where should be seeing dramatic increases in NIH notices of awards (NOAs)

Graphs: New SBIR and RO1 award notifications in 2025 compared to prior years.

Data from NIH RePORTER, code to reproduce here:
gist.github.com/chasemc/fda6...

Would you pay $150 per article to post your preprint on @bioRxiv @aRxiv @medRxiv @chemRxiv etc.? Currently it’s free but a small cost could help offset running costs and also work as a barrier against paper mills and AIs just posting all the time and filling these sites up.

In this day & age I would believe it, sadly

YouTube video by U.S. Food and Drug Administration FDA & NIH Workshop on Reducing Animal Testing

youtu.be/vz1uF42wnKQ?... to watch the workshop

NIH announces end to funding for animal-only studies - Drug Discovery and Development Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.

This does not seem to be a good policy (cell based models can only go so far), but I will reserve judgement until NIH publishes an actual, official policy on animal use in grant applications www.drugdiscoverytrends.com/nih-announce...